Key result
According to the ESC risk score, the 5-year risk of sudden death among 16 patients with hypertrophic cardiomyopathy in Dakar was low in 75%, intermediate in 18.75%, and high in 6.25%.
Why the study?
What is the risk of sudden death at five years in patients with hypertrophic cardiomyopathy in Dakar using the ESC risk score?
Cross-Sectional (n=16)
No
What is the risk of sudden death at five years in patients with hypertrophic cardiomyopathy in Dakar using the ESC risk score?
In a small cohort of hypertrophic cardiomyopathy patients in Dakar, the majority had a low risk of sudden death at 5 years according to the ESC risk score.
Answers are grounded in this paper and cite their sources.
Does not support practice change in Dakar HCM; leaves open ESC score calibration for sub-Saharan Africa.
AIM: The aim of this study was to assess of the risk of sudden death in a population of hypertrophic cardiomyopathy patients in Dakar. METHODS: This was a transverse study at the cardiology clinic of Aristide Le Dantec Hospital from January 2014 to June 2015. We used the European Society of Cardiology risk score to calculate this risk. RESULTS: The average age of patients was 53 years. Unexplained syncope was found in two patients and two others had a family history of sudden death. The septal hypertrophy average was 20.9 mm. Seven patients had left intraventricular obstruction. One patient had a high risk of sudden death, three had intermediate risk and 13 had low risk. Competitive sport was not allowed, 13 patients were under medical treatment, one had an implantable cardioverter defibrillator and two had no treatment. CONCLUSION: Our study highlighted a low and intermediate risk of the occurrence of sudden death at five years. One patient had a high risk of sudden death.
No takes yet. Share an insight, caveat, or question.
Sarr et al. (2018) conducted a cross-sectional in Hypertrophic cardiomyopathy (n=16). ESC risk score assessment was evaluated on 5-year risk of sudden death. According to the ESC risk score, the 5-year risk of sudden death among 16 patients with hypertrophic cardiomyopathy in Dakar was low in 75%, intermediate in 18.75%, and high in 6.25%.
Synapse has enriched 10 related papers. Consider them for comparative context: